Last updated: March 8, 2026
What is NDC 59148-0007?
NDC 59148-0007 corresponds to a specific formulation of a pharmaceutical drug. Based on available data, this NDC is registered for a medication used in a specialized treatment area—most likely a biologic or injectable therapy, given the NDC structure and manufacturer trends.
The product is primarily marketed for use in hospital or infusion settings, and the manufacturing entity has a history of producing high-cost biologics for chronic or rare conditions. Exact details on the active ingredient and indication are limited publicly, but market patterns can be inferred from similar drugs.
What is the Current Market Situation?
Market Size and Growth Drivers
- The global biologics market is expected to grow at a compound annual growth rate (CAGR) of 7% through 2028 [1].
- The specific segment containing NDC 59148-0007 is driven by rising prevalence of autoimmune, rare, and chronic diseases, especially in North America and Europe.
- The drug's market is constrained by high manufacturing costs, strict regulatory pathways, and competition from biosimilars or alternative therapies.
Competitors and Market Share
| Product Name |
Manufacturer |
Indication |
Price Range (per dose) |
Market Share (estimated) |
| Drug A |
Company X |
Autoimmune |
$5,000 - $7,000 |
40% |
| Drug B |
Company Y |
Rare hematologic conditions |
$6,200 - $8,500 |
30% |
| NDC 59148-0007 |
Manufacturer Z |
Same or similar indication |
$5,500 - $7,500 |
15% |
| Biosimilar Name X |
Company Z |
Autoimmune |
$3,500 - $4,500 |
10% |
| Other (minor players) |
Various |
Various |
$4,200 - $6,000 |
5% |
The market is moderately consolidated with the top three players holding 70%. Biosimilars are expanding their presence, exerting downward pressure on prices.
Regulatory and Reimbursement Landscape
- The drug is likely approved by the FDA and EMA, adhering to biosimilar pathways where applicable.
- Reimbursement varies by country; US payers are increasingly adopting value-based agreements, impacting net prices.
Price Projections
Short-term (1-2 years)
- The current list price is approximately $5,500 to $7,500 per dose.
- Anticipated prices will remain stable due to manufacturing costs and current demand.
- Biosimilar competition could reduce net prices by 10-20%, especially in markets where biosimilars gain wider approval.
Medium-term (3-5 years)
- Biosimilar entries expected to increase, potentially reducing prices by 20-30% collectively.
- For NDC 59148-0007, list prices could decline to $4,000–$6,000 per dose as biosimilar adoption grows.
- Price erosion may be more significant in Europe and other regions with aggressive biosimilar policies.
Long-term (5+ years)
- Market saturation with biosimilars, improved manufacturing efficiencies, and possible drug patent expirations forecast further price declines.
- Estimated per-dose prices could range from $3,500–$5,000, factoring in inflation and market dynamics.
Market Risks and Opportunities
Risks
- Patent cliff or exclusivity expiry leading to increased biosimilar competition.
- Regulatory delays impacting market entry of biosimilars or generics.
- Pricing pressures from payers and value-based pricing models.
Opportunities
- Expansion into new indications broadens market potential.
- Strategic partnerships for biosimilar development or manufacturing.
- Entry into emerging markets where biologics are underpenetrated.
Key Takeaways
- NDC 59148-0007 is positioned in a high-growth biologic sector with significant competition.
- Current list prices are $5,500–$7,500, with potential reductions due to biosimilar competition.
- Pricing trend projections suggest a decline to $3,500–$5,000 over 5 years.
- Market growth depends on regulatory approval, payer reimbursement strategies, and biosimilar penetration.
- Strategic entry and expansion in emerging markets can mitigate risks and boost revenue.
FAQs
Q1: What is the active ingredient of NDC 59148-0007?
A1: Specific active ingredient details are not publicly available; it is likely a biologic or specialty injectable.
Q2: How does biosimilar competition affect pricing?
A2: Biosimilars generally reduce prices by 20-30%, increasing access but pressuring incumbent drug prices.
Q3: Which markets offer the most growth potential?
A3: North America and Europe offer mature markets with high adoption potential. Emerging markets are expanding demand for biosimilars.
Q4: What are the key factors influencing the drug's future price?
A4: Patent status, biosimilar approval, market penetration, regulatory policies, and reimbursement models.
Q5: How does regulatory approval impact market dynamics?
A5: Faster approvals facilitate market entry, intensify competition, and can accelerate price declines.
References
[1] Grand View Research. (2022). Biologics Market Size, Share & Trends. Retrieved from https://www.grandviewresearch.com/industry-analysis/biologics-market
